Brief: VBI Vaccines Says PreHevbrio Available In U.S.
29/03/2022 13:17
March 29 (Reuters) - VBI Vaccines Inc VBIV.O :
* VBI VACCINES - PREHEVBRIO NOW AVAILABLE IN U.S. FOR
PREVENTION
OF INFECTION CAUSED BY ALL KNOWN SUBTYPES OF HEPATITIS B VIRUS
IN ADULTS AGE 18 YEARS & OLDER
Source text for Eikon: ID:nBw7s22Gra
Further company coverage: VBIV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VBI Vaccines
See all newsBrief: VBI Vaccines Provides Update On Its Restructuring Proceedings
Brief: Vbi Vaccines Announces New Tumor Response Data From Ongoing Randomized Controlled Phase 2B Study Of Vbi-1901 In Recurrent Glioblastoma Patients
VBI Vaccines Inc reports results for the quarter ended in March - Earnings Summary
Brief: VBI Vaccines Says Entered At Market Offering Deal For Gross Proceeds Of Up To $8.5 Mln
Brief: VBI Vaccines Q1 Adjusted EPS USD -0.55